Rokshaw can today announce the exclusive UK manufacture and distribution of medical cannabis products, under the Four20 Pharma brand.
In line with market growth and patient demand, Rokshaw have bolstered its extensive range of medical cannabis, supplying Four20 Pharma products now available for private prescription in the UK.
Originating from Germany, Four20 Pharma have a EU-GMP approved portfolio of high quality strains and terpene profiles. With unique growing conditions and preparation through cultivation processes, specific product profiles are selected to sit within this range. Manufacture and distribution from Rokshaw ensures a consistency of supply for specialist doctors to prescribe to their patients.
https://rokshaw.co.uk/news/launch-of-four20-pharma-medical-cannabis-range/